Tokio Marine Asset Management’s Avantor AVTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-26,513
Closed -$357K – 537
2025
Q2
$357K Buy
26,513
+3,166
+14% +$43.3K 0.01% 523
2025
Q1
$378K Buy
23,347
+516
+2% +$9.77K 0.01% 526
2024
Q4
$481K Buy
22,831
+1,727
+8% +$38.8K 0.02% 489
2024
Q3
$546K Hold
21,104
– – 0.02% 445
2024
Q2
$447K Buy
21,104
+405
+2% +$9.75K 0.02% 452
2024
Q1
$529K Buy
20,699
+1,974
+11% +$47K 0.03% 420
2023
Q4
$427K Buy
18,725
+685
+4% +$14K 0.02% 443
2023
Q3
$380K Buy
18,040
+800
+5% +$17K 0.02% 440
2023
Q2
$354K Buy
17,240
+1,187
+7% +$24K 0.02% 437
2023
Q1
$339K Buy
16,053
+3,017
+23% +$68.8K 0.02% 428
2022
Q4
$275K Buy
13,036
+1,390
+12% +$28.8K 0.02% 451
2022
Q3
$228K Buy
11,646
+1,822
+19% +$48.8K 0.02% 448
2022
Q2
$306K Buy
9,824
+2,147
+28% +$67K 0.03% 368
2022
Q1
$260K Buy
7,677
+769
+11% +$27.4K 0.02% 410
2021
Q4
$291K Buy
6,908
+603
+10% +$23.8K 0.02% 369
2021
Q3
$258K Buy
6,305
+589
+10% +$23K 0.02% 384
2021
Q2
$203K Buy
+5,716
New +$185K 0.02% 434

Other funds holding AVTR

Tokio Marine Asset Management's AVTR Position: Q3 2025 in Review

Tokio Marine Asset Management sold out of Avantor (AVTR) in Q3 2025, closing a stake of 26,513 shares — an estimated $357K sold.

Tokio Marine Asset Management first reported a position in AVTR in Q2 2021 and held it in 17 quarters. The position peaked at $546K in Q3 2024. 466 funds tracked by Wall St. Rank hold AVTR as of Q3 2025.

  • Tokio Marine Asset Management reported no remaining Avantor position as of Q3 2025 after selling out during the quarter.
  • Tokio Marine Asset Management sold 26,513 Avantor shares in Q3 2025, an estimated $357K.
  • Tokio Marine Asset Management first reported a position in Avantor in Q2 2021 and held it in 17 quarters.
  • Tokio Marine Asset Management's Avantor position peaked at $546K in Q3 2024.
  • 466 funds tracked by Wall St. Rank held Avantor as of Q3 2025.

Based on Tokio Marine Asset Management's 13F filing for Q3 2025, filed 27 Oct 2025.